20/20 Biolabs, Inc. Common Stock

20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. The company is headquartered in Rockville, Maryland. The firm offers OneTest, a simple blood test for multiple cancers, harnesses the power of Artificial Intelligence (AI) to help identify the disease at an earlier, more treatable stage. Onetest helps detect Lung, Liver, Pancreatic, Prostate, Kidney, Ovarian and many other cancers with a single blood test.